Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Structure of the blood-brain barrier
-
1. The blood-brain barrier in Alzheimer’s disease
- Dr. Anika Hartz
-
2. Tanycytes allow a tight BBB in the median eminence
- Prof. Esteban Rodriguez
- Dr. Juan Luis Blazquez
- Dr. Montserrat Guerra
- Nutrient transport
-
3. Blood-brain barrier ion transport
- Prof. Martha O'Donnell
- Peptides and proteins
-
4. Ingestive peptides
- Prof. William Banks
-
5. Blood-brain barrier in health and disease
- Prof. Thomas Davis
- Overcoming the blood-brain barrier obstacle
-
6. Expression vs. function of ABC transporters at the blood-brain barrier
- Prof. Jean-Michel Scherrmann
-
7. The blood-brain barrier and CNS drug development
- Dr. Danica Stanimirovic
- Diseases involving the blood-brain barrier
-
9. Inflammation and immune cell entry to the central nervous system
- Prof. Serge Rivest
-
11. Ischemic blood-brain barrier and Alzheimer's amyloid plaques development
- Prof. Ryszard Pluta
- Latest Developments in the Field
-
12. MRI approaches for neurovascular imaging
- Dr. Rick Dijkhuizen
-
13. Brain-gut interactions in obesity 1
- Prof. Weihong Pan
-
14. Brain-gut interactions in obesity 2
- Prof. Weihong Pan
- Archived Lectures *These may not cover the latest advances in the field
-
15. Neurotrophins and the BBB
- Prof. Weihong Pan
-
16. Vasoactive peptides and the blood-brain barrier
- Prof. Maria Deli
- Prof. Bela Kis
-
17. In vivo systems
- Prof. Quentin Smith
-
18. CNS-drug design
- Prof. Quentin Smith
-
20. Stroke and the BBB
- Prof. Marilyn Cipolla
-
21. Barrier mechanisms in the developing brain: mechanisms and misunderstandings
- Prof. Norman Saunders
-
22. Barrier mechanisms in the developing brain: protection or vulnerability?
- Prof. Norman Saunders
-
23. In vitro models of the blood-brain barrier
- Prof. Pierre-Olivier Couraud
-
24. Glucose transport across the blood-brain barrier
- Prof. Luc Leybaert
-
25. The blood-brain barrier and brain tumors
- Dr. Olaf van Tellingen
-
26. Cellular composition of the blood-brain barrier
- Prof. N. Joan Abbott
-
27. Features of mammalian CNS barrier systems
- Prof. Conrad Johanson
Printable Handouts
Navigable Slide Index
- Introduction
- Part II
- Shifting from neuron-centric approaches
- Upregulation of astrocytic obese receptor (ObR)
- Astrocytic ObR in diet-induced obesity (DIO)
- Leptin induces calcium signaling in astrocytes
- Astrocytes regulate leptin resistance in obesity
- Astrocytes regulate leptin transport & signaling
- Astrogliosis shifts balance of leptin signaling
- Vascular, glial, and lymphatic immune gateways
- How the BBB connects the microbiome & brain
- Gut microbiota modulate neurobehavior
- DIO hypometabolic state of the BBB (1)
- DIO hypometabolic state of the BBB (2)
- DIO hypometabolic state of the BBB (3)
- Summary of brain-gut interactions in obesity
- Other key references
Topics Covered
- Glial cells in the reaction and regulation of obesity
- The gut as a large immune organ, and interface with the BBB
- “Vascular, glial, and lymphatic immune gateways” of neuroimmune modulation
- Metabolic changes of the BBB in obesity besides cytokine transport across the BBB
- Implications in the pathophysiology of neurodegenerative diseases
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pan, W. (2019, February 27). Brain-gut interactions in obesity 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/WAQZ2501.Export Citation (RIS)
Publication History
Financial Disclosures
- Professor Weihong Pan has no commercial/financial relationships to disclose
Brain-gut interactions in obesity 2
Published on February 27, 2019
19 min
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:04
So far, we have discussed the BBB permeation
of ingestive peptides with leptin as a major example.
We have discussed the different mechanisms of permeation and trans-BBB signaling,
and the contribution of
circumventricular organs in the crosstalk between the CNS and periphery.
We will now move on to glial biology in feeding and obesity regulation.
0:31
Not all astrocytes participate in BBB functions,
but many astrocytes contribute to the BBB with their NP and the basic QD molecules.
In the world of neuroendocrine control of obesity,
neurons initially attracted the most attention.
Gradually, the field is paying more attention to glial cells because
of observed the reactive gliosis changes in astrocytes and microglia.
This is mainly caused by obesity related neuro inflammation.
Our group was among the first to report how obesity
regulates astro acidic leptin receptor or ObR expression,
and how the reactive astrocytes in turn modulated feeding behavior and obesity.
We will elaborate on the regulation of
the astro acidic leptin system in obesity in the following slides.
1:32
In the arcuate nucleus of the mice hypothalamus,
immunofluorescence staining of leptin receptor ObR shows two types of cells.
A circular pattern belongs to cell surface and cytoplasm of
neurons as shown by double labeling with a neuronal maker such as new n. Thus,
any pattern shows cellular processes and is expressed by astrocytes as confirmed
by colocalization with an astro acidic marker such as GFP or S100 beta.
In a lean mouse,
there are more neurons expressing leptin receptor in this region,
in an age and sex matched AVY mouse with
adult onset obesity resulting from genetic changes.
There are more ObR positive astrocytes.
Then, C in elite C57B6 mouse.
This provides the first evidence that obesity might up regulate astro acidic ObR.